Objectives: We reviewed the feasibility and safety of nephron sparing surgery for renal cell carcinoma in patients with von Hippel Lindau (VHL) disease.

Methods: We selected 22 patients with (VHL) disease with a mean age of 43 (range 30-56), from whom 16 underwent radical nephrectomy or nephron sparing surgery at our department between 2000 and 2015.

Results: A total of 33 tumors were treated, by either tumorectomy (n=20), partial nephrectomy (n=5), percutaneous renal radiofrequency ablation (n=3) edaor radical nephrectomy (n=5). All procedures were successfully completed without intraoperative and postoperative complications. The diameter of the tumor ranged from 2.8 to 4.8 cm. The interval between treatments in patients operated more than once was 40 months. Renal function stayed stable with basal creatinine and current creatinine 0.74 ± 0.21 mg/dl and 0.93 ± 0.22 mg/dl respectively. Median follow-up was 72.3 months. Cancer-specific survival was 97%.

Conclusions: nephron sparing surgery in renal tumors >3 cm is an effective and safe treatment for VHL patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nephron sparing
16
sparing surgery
12
cell carcinoma
8
surgery renal
8
radical nephrectomy
8
nephrectomy n=5
8
[renal cell
4
carcinoma von
4
von hippel-lindau
4
hippel-lindau disease
4

Similar Publications

Background And Aim: In this retrospective single center cohort study, we report the surgical outcomes of nephron-sparing surgery (NSS) for Wilms' tumor (WT) patients since centralization of pediatric oncology care in the Netherlands, and implementation of technological advancements. Therewith we describe the influence of experience and innovations for this type of surgery.

Methods: We retrospectively assessed all NSS procedures from January 1st 2015 until January 1st 2024 for patients who underwent surgery for a renal tumor at the Princess Máxima Center for Pediatric Oncology.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the predictive accuracy of a new nephrometry model (RSR) for nephron-sparing surgery in pediatric patients with Wilms tumor, comparing it to existing models.
  • Data from 58 pediatric patients were analyzed, calculating nephrometry scores such as RENAL, PADUA, and SPARE, and the RSR model showed superior predictive performance with an area under the curve (AUC) of 0.982.
  • The RSR model not only outperformed the other nephrometry scores significantly but also demonstrated good inter-rater reliability, leading to the development of a user-friendly web-based calculator for its application.
View Article and Find Full Text PDF

Background And Aims: Outcome analysis of patients with Wilms' tumors (WT) is presented.

Materials And Methods: A retrospective analysis of 23 children having WT managed by a single surgeon over 3 years (2021-2024) using the International Society of Paediatric Oncology Umbrella protocol was done.

Results: The median age at presentation was 36 months; 32 months and 24 months for the unilateral WT (uWT) ( = 19) and bilateral WT (bWT) ( = 4), respectively.

View Article and Find Full Text PDF

Introduction: This study aims to evaluate the impact of preoperative ureteral stenting on postoperative outcomes, especially the incidence of urinoma, in patients with complex renal tumors undergoing nephron-sparing surgery.

Methods: A retrospective analysis of 35 patients who received preoperative ureteral stenting prior to nephron-sparing surgery for complex tumors at the University Hospital of Würzburg between 2002 and 2021. A control group of 115 patients was established through 1:3 propensity score matching based on age, gender, T-stage, and RENAL score.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!